Sale of DocMorris

HG Capital Trust PLC
27 April 2007


The following is the text of a press release issued by HgCapital, which manages
the investment portfolio of HgCapital Trust plc alongside those of other
institutional clients.


On completion of the sale of DocMorris, HgCapital Trust plc, a listed investment
trust giving investors the opportunity to participate in all of HgCapital's
investments, will realise a total of £5.1 million. The impact of the realisation
on the net asset value of HgCapital Trust plc will be an increase of
approximately 12.7p per share over the published 31st March 2007 net asset
value.


          3i, HgCapital and Neuhaus Partners sell DocMorris to Celesio


Frankfurt/Main, April 27, 2007. The European private equity companies 3i and
HgCapital along with venture-capital investor Neuhaus Partners are selling their
stakes in mail-order pharmacy DocMorris, domiciled in Heerlen in the Netherlands
. The buyer is Celesio AG, Europe's largest pharmaceutical distributor, which
will become the majority shareholder in DocMorris. The company's management will
continue to hold a stake of just under 10 per cent in DocMorris. The transaction
is expected to close at the end of May. The purchase price is being kept
confidential.


In recent years, the financial investors together with the DocMorris management
team have made focused investments to accelerate the company's growth. In
particular, they supported DocMorris in expanding its business model from a pure
mail-order business to include pharmacy business. Today, DocMorris has around
850,000 mail order customers. The company, which has 330 employees achieved a 16
per cent rise in sales last year to €172 million; further strong growth in 2007
is expected. Thus, within the space of only seven years since start-up,
DocMorris has become an established player in the pharmaceutical sector.


Achim Lederle, Partner at 3i Germany, comments: 'We are very happy that
DocMorris will continue its outstanding development with Celesio as the new
partner. In the years of our involvement, we made certain our network was at the
disposal of the DocMorris management and, as an active supervisory board member,
we set the strategic course. DocMorris played an important role in the
restructuring of the pharmaceutical market, and in so doing advanced the
development of an entire sector.'


Philipp Schwalber of HgCapital explains: 'DocMorris was a highly successful
investment for HgCapital. In recent years the company has performed superbly and
achieved all its targets. DocMorris has established an excellent launch pad for
itself ready for the forthcoming deregulation of the German pharmaceutical
market. With Celesio as a strong strategic partner at its side, the company has
bright prospects, and the course for the future is set.'

Gottfried Neuhaus of Neuhaus Partners says: 'As a founding investor we have been
actively involved in DocMorris' history from its beginnings through to today. We
are pleased that in Celesio we have found a buyer who will provide the next
boost to DocMorris growth and together with the outstanding management team will
continue the company's success story.'



For further details:

3i Deutschland Gesellschaft fur

Industriebeteiligungen mbH

Christiane L. Dohler                             [phone]


Citigate Dewe Rogerson GmbH                      [phone]
Matthias Link



About 3i

3i is a leading global private equity company for majority and minority holdings
in medium-sized companies. In addition to furnishing equity, 3i also offers its
portfolio companies wide-ranging know-how and access to the broad international
3i network. Alongside its core business, namely medium-sized buyouts, growth and
infrastructure financing, 3i is also active in the venture capital market, with
selective start-up and seed capital financing. 3i sees itself as the partner of
the portfolio companies and focuses its activities on the partners' mutual
success.

3i is represented in 14 countries on three continents (Europe, Asia and North
America). Last business year, the 3i Group invested about € 1.4 billion.


For further details, click www.3i.com.



HgCapital

Philipp Schwalber                               [phone]

HERING SCHUPPENER Consulting                    [phone]
Georg Jakobs



About HgCapital

HgCapital is a private-equity investor in the European mid-market. We focus on
investments with an enterprise value in the range of € 50-500 million. Our
business model combines sector specialisation with dedicated, pro-active support
to our portfolio companies as well as the corresponding management expertise
across all phases of the investment process. HgCapital manages more than € 2.7
billion for some of the world's most respected institutional and private
investors. Our goal is to achieve outstanding results for our investors,
management team and intermediaries.


For further details, click www.hgcapital.com.

Neuhaus Partners

Dr. Gottfried Neuhaus                   [phone] - 0

Dr. Pablo Fetter                        [phone] - 0



About Neuhaus Partners:

Neuhaus Partners GmbH (formerly Dr. Neuhaus Techno Nord), based in Hamburg, was
founded in 1997 by Dr. Gottfried Neuhaus and is one of Germany's leading
independent venture capital corporations. It invests throughout Europe in
technology companies. Since its foundation, it has acquired a total of 36
stakes, among others in mobile telephony provider blau.de - in 34 of the
companies Neuhaus Partners entered as the lead investor. Track Record: Two IPOs,
15 trade sales, two buy-backs, nine insolvencies. At present, Neuhaus Partners
is in the fundraising process for a new € 100 million technology fund. First
closing for this new fund 'Neuhaus III' was in December 2006.


For further details on Neuhaus Partners visit www.NeuhausPartners.com


About DocMorris

Doc Morris is Germany's best known pharmaceutical brand and at the same time
Europe's biggest mail-order pharmacy with sales of €172 million in 2006. The
headquarters of the company is situated in Heerlen in the Netherlands. About 330
people work there on the success of the Doc Morris network. In 2006 Doc Morris
has set up a branch in its primary market Germany in Saarbrucken. Since 2007,
Doc Morris cooperates nationwide with on-site pharmacies. Until April, already
20 pharmacies from 7 federal states have entered a brand partnership. Doc Morris
plans to win 500 pharmacies as cooperation partners throughout the next 3 to 5
years.


For further details on DocMorris please visit www.docmorris.de.



                      This information is provided by RNS
            The company news service from the London Stock Exchange